Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03724890 |
Title | Study of Avelumab-M3814 Combinations |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | EMD Serono Research & Development Institute, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
H. Lee Moffitt Cancer Center and Research Institute, Inc | Tampa | Florida | 33612 | United States | Details | |
The University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
Mount Sinai - PRIME (10707) | Lake Success | New York | 11041 | United States | Details | |
UC Health Clinical Trials Office (10702) | Cincinnati | Ohio | 45267-0502 | United States | Details | |
University of Oklahoma Health Sciences Center - Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
University of Pittsburgh Medical Center Health System | Pittsburgh | Pennsylvania | 15213 | United States | Details | |
Greenville Hospital System University Medical Center (ITOR) | Greenville | South Carolina | 29605 | United States | Details | |
Vanderbilt-Ingram Cancer Center (8867) | Nashville | Tennessee | 37212 | United States | Details |